The Pew Charitable Trusts and eight other groups representing patients, clinicians, and medical device manufacturers are pushing Congress to include legislation in the year-end omnibus spending package that would finally update regulation of laboratory-developed tests (LDTs).
Currently regulated under the 1988 Clinical Laboratory Improvement Amendments (CLIA), LTDs are not centrally registered or tracked, which proponents of reform say makes it difficult to assess their efficacy